SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-24-000336
Filing Date
2024-02-09
Accepted
2024-02-09 20:36:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da112927020_02092024.htm SC 13D/A 293092
  Complete submission text file 0000921895-24-000336.txt   294826
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91228 | Film No.: 24617079
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009
Business Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009 646-844-0037
Velan Capital Investment Management LP (Filed by) CIK: 0001848809 (see all company filings)

IRS No.: 844706623 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A